Background: Alzheimer’s disease (AD) is a devastating neurodegenerative disorder. In recent years, attention of researchers has increasingly been focused on studying the role of brain insulin resistance (BIR) in the AD pathogenesis. Neuroinflammation makes a significant contribution to the BIR due to the activation of NLRP3 inflammasome. This study was devoted to the understanding of the potential therapeutic roles of the NLRP3 inflammasome in neurodegeneration occurring concomitant with BIR and its contribution to the progression of emotional disorders. Methods: To test the impact of innate immune signaling on the changes induced by Aβ1-42 injection, we analyzed animals carrying a genetic deletion of the Nlrp3 gene. Thus, we studied the role of NLRP3 inflammasomes in health and neurodegeneration in maintaining brain insulin signaling using behavioral, electrophysiological approaches, immunohistochemistry, ELISA and real-time PCR. Results: We revealed that NLRP3 inflammasomes are required for insulin-dependent glucose transport in the brain and memory consolidation. Conclusions NLRP3 knockout protects mice against the development of BIR: Taken together, our data reveal the protective role of Nlrp3 deletion in the regulation of fear memory and the development of Aβ-induced insulin resistance, providing a novel target for the clinical treatment of this disorder.
Astrogliosis is a pathological process that affects the density, morphology, and function of astrocytes. It is a common feature of brain trauma, autoimmune diseases, and neurodegeneration including spinocerebellar ataxia type 1 (SCA1), a poorly understood neurodegenerative disease. S100β is a Ca2+ binding protein. In SCA1, excessive excretion of S100β by reactive astrocytes and its uptake by Purkinje cells has been demonstrated previously. Under pathological conditions, excessive extracellular concentration of S100β stimulates the production of proinflammatory cytokines and induces apoptosis. We modeled astrogliosis by S100β injections into cerebellar cortex in mice. Injections of S100β led to significant changes in Bergmann glia (BG) cortical organization and affected their processes. S100β also changed morphology of the Purkinje cells (PCs), causing a significant reduction in the dendritic length. Moreover, the short-term synaptic plasticity and depolarization-induced suppression of synaptic transmission were disrupted after S100β injections. We speculate that these effects are the result of Ca2+-chelating properties of S100β protein. In summary, exogenous S100β induced astrogliosis in cerebellum could lead to neuronal dysfunction, which resembles a natural neurodegenerative process. We suggest that astrocytes play an essential role in SCA1 pathology, and that astrocytic S100β is an important contributor to this process.
29 August 2024 in Biochemical and Biophysical Research Communications
Pain is a complex phenomenon that involves sensory, emotional, and cognitive components. The posterior insula cortex (pIC) has been shown to integrate multisensory experience with emotional and cognitive states. However, the involvement of the pIC in the regulation of affective behavior in pain remains unclear. Here, we investigate the role of pain-related pIC neurons in the regulation of anxiety-like behavior during acute pain. We combined a chemogenetic approach with targeted recombination in active populations (TRAP) in mice. Global chemogenetic inhibition of pIC neurons attenuates chemically-induced mechanical hypersensitivity without affecting pain-related anxiety-like behavior. In contrast, inhibition of pain-related pIC neurons reduces both mechanical hypersensitivity and pain-related anxiety-like behavior. The present study provides important insights into the role of pIC neurons in the regulation of sensory and affective pain-related behavior.
16 May 2026 in Annals of the Russian academy of medical sciences
This review systematizes modern bioengineering strategies for modeling tissue barriers, neurovascular unit (NVU) and perivascular unit (PVU) for translational neuroscience. The aim is to provide a critical analysis of the current understandings of neuroplasticity, organization of NVU, PVU and blood-brain barrier as well as advantages and limitations of currently available in vitro microphysiological models. It is clear that, despite progress in replicating three-dimensional architecture, the next key challenge is to imitate the temporal dynamics of histogenesis (angiogenesis, barrierogenesis, neurogenesis). This defines the transition towards the development of a novel class of 4D models capable of spatiotemporal self-organization. The analysis reveals the necessity to adapt model complexity to the target function: highly complex systems are a priority for fundamental research into plasticity and pathogenesis of nervous system disorders, while standardized platforms are well-suited for high-throughput pharmacological screening. It is concluded that creating relevant, validated platforms remains a critical interdisciplinary task. This will help bridge the gap between preclinical and clinical research, enhancing the reliability of studying pathological mechanisms and the preclinical evaluation of therapeutic agents.
30 March 2026 in Annals of Clinical and Experimental Neurology
Introduction. The blood-brain barrier (BBB) is a component of the neurovascular unit and a system regulating chemical homeostasis in brain tissue. Assessment of BBB permeability under normal and abnormal states of the central nervous system is of significant interest for experimental research in neuroscience. In recent years, there has been a substantial expansion of protocols that can be used to address such research tasks. Understanding the key differences, advantages, and limitations of each BBB investigation method is crucial for proper experimental design and data interpretation. The aim of this review is to analyze modern methods for assessing BBB permeability in laboratory animals using fluorescent probes (tracers), provide their comparative characteristics, and evaluate selection criteria for solving experimental tasks. Conclusion. Fluorescent probes enable real-time monitoring of BBB status in vivo during experimental neuroscience studies when assessing structural and functional integrity of the barrier in neuroinflammation, neurodegeneration, and brain tissue injury. Proper selection of fluorescent probes allows differentiated evaluation of para- and transcellular BBB permeability, vascular wall structure, and processes associated with brain tissue clearance.